文献速递消化道肿瘤放疗放疗物理与技术

新型四维磁共振成像显示肿瘤浸润血管:刻画胰腺放疗中选择性 Boost 靶区定义的肿瘤与血管体积运动

Novel 4D-MRI of tumor infiltrating vasculature: characterizing tumor and vessel volume motion for selective boost volume definition in pancreatic radiotherapy.
PubMed 文献 · Radiat Oncol · 2018-10-01

该研究纳入 10 例临界可切除或局部晚期胰腺癌患者,比较 slab 选择性激励与非选择性四维磁共振成像及延迟增强四维 CT 对肿瘤浸润血管的显示。结果显示 slab 选择性四维磁共振成像的血管-组织对比噪声比最高,肿瘤与受累血管运动轨迹在头脚方向的组内相关系数为 0.93 ± 0.10。

要点

  • slab 选择性四维磁共振成像的受累血管平均对比噪声比为 13.1 ± 8.4,四维 CT 为 3.2 ± 2.7。
  • 肿瘤与受累血管运动轨迹的组内相关系数在头脚、前后、左右方向分别为 0.93 ± 0.10、0.65 ± 0.31、0.77 ± 0.23。
  • 该序列在同步整合 boost 的胰腺放疗中准确勾画肿瘤与 boost 体积边界方面具有很大潜力。

核心结论

  • 基于三维径向采样和 slab 选择性激励的新型四维磁共振成像序列已在胰腺癌患者中评估,非增强四维磁共振成像对限制肿瘤可切除性的血管显示的对比噪声比显著优于延迟增强四维 CT。

研究设计与样本

  • 研究纳入 10 例连续入组的临界可切除或局部晚期胰腺癌患者,所有患者均接受非增强四维磁共振成像(含与不含 slab 选择性激励)及延迟增强四维 CT 检查。

主要发现

  • 在所有评估的四维成像模态中,slab 选择性四维磁共振成像采样轨迹所得图像的血管-组织对比噪声比在所有研究患者中均最高。
  • 受累血管的平均(±标准差)对比噪声比在 slab 选择性四维磁共振成像为 13.1 ± 8.4,在四维 CT 为 3.2 ± 2.7。
  • 比较肿瘤与受累血管运动轨迹的组内相关系数在头脚方向为 0.93 ± 0.10,前后方向为 0.65 ± 0.31,左右方向为 0.77 ± 0.23。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatic ductal adenocarcinoma has dismal prognosis. Most patients receive radiation therapy (RT), which is complicated by respiration induced organ motion in upper abdomen. The purpose of this study is to report our early clinical experience in a novel self-gated k-space sorted four-dimensional magnetic resonance imaging (4D-MRI) with slab-selective (SS) excitation to highlight tumor infiltrating blood vessels for pancreatic RT. METHODS: Ten consecutive patients with borderline resectable or locally advanced pancreatic cancer were recruited to the study. Non-contrast 4D-MRI with and without slab-selective excitation and 4D-CT with delay contrast were performed on all patients. Vessel-tissue CNR were calculated for aorta and critical vessels (superior mesenteric artery or superior mesenteric vein) encompassed by tumor. Respiratory motion trajectories for tumor, as well as involved vessels were analyzed on SS-4D-MRI. Intra-class cross correlation (ICC) between tumor volume and involved vessels were calculated. RESULTS: Among all 4D imaging modalities evaluated, SS-4D-MRI sampling trajectory results in images with highest vessel-tissue CNR comparing to non-slab-selective 4D-MRI and 4D-CT for all patients studied. Average (±standard deviation) CNR for involved vessels are 13.1 ± 8.4 and 3.2 ± 2.7 for SS-4D-MRI and 4D-CT, respectively. The ICC factors comparing tumor and involved vessels motion trajectories are 0.93 ± 0.10, 0.65 ± 0.31 and 0.77 ± 0.23 for superior-inferior, anterior-posterior and medial-lateral directions respectively. CONCLUSIONS: A novel 4D-MRI sequence based on 3D-radial sampling and slab-selective excitation has been assessed for pancreatic cancer patients. The non-contrast 4D-MRI images showed significantly better contrast to noise ratio for the vessels that limit tumor resectability compared to 4D-CT with delayed contrast. The sequence has great potential in accurately defining both the tumor and boost volume margins for pancreas RT with simultaneous integrated boost.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yang W, Fan Z, Deng Z, et al. Novel 4D-MRI of tumor infiltrating vasculature: characterizing tumor and vessel volume motion for selective boost volume definition in pancreatic radiotherapy. Radiat Oncol. 2018. PMID: 30285889. doi:10.1186/s13014-018-1139-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。